VERACYTE INC (VCYT) Fundamental Analysis & Valuation

NASDAQ:VCYT • US92337F1075

Current stock price

33.48 USD
+0.56 (+1.7%)
At close:
33.48 USD
0 (0%)
After Hours:

This VCYT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. VCYT Profitability Analysis

1.1 Basic Checks

  • VCYT had positive earnings in the past year.
  • In the past year VCYT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: VCYT reported negative net income in multiple years.
  • Of the past 5 years VCYT 4 years had a positive operating cash flow.
VCYT Yearly Net Income VS EBIT VS OCF VS FCFVCYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • With an excellent Return On Assets value of 4.72%, VCYT belongs to the best of the industry, outperforming 91.12% of the companies in the same industry.
  • VCYT has a better Return On Equity (5.07%) than 90.54% of its industry peers.
  • The Return On Invested Capital of VCYT (4.59%) is better than 90.93% of its industry peers.
Industry RankSector Rank
ROA 4.72%
ROE 5.07%
ROIC 4.59%
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
VCYT Yearly ROA, ROE, ROICVCYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • VCYT's Profit Margin of 12.83% is amongst the best of the industry. VCYT outperforms 91.89% of its industry peers.
  • Looking at the Operating Margin, with a value of 15.14%, VCYT belongs to the top of the industry, outperforming 92.28% of the companies in the same industry.
  • VCYT's Gross Margin of 70.10% is amongst the best of the industry. VCYT outperforms 80.89% of its industry peers.
  • VCYT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.14%
PM (TTM) 12.83%
GM 70.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
VCYT Yearly Profit, Operating, Gross MarginsVCYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

8

2. VCYT Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VCYT is destroying value.
  • Compared to 1 year ago, VCYT has more shares outstanding
  • The number of shares outstanding for VCYT has been increased compared to 5 years ago.
  • VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VCYT Yearly Shares OutstandingVCYT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VCYT Yearly Total Debt VS Total AssetsVCYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • An Altman-Z score of 16.81 indicates that VCYT is not in any danger for bankruptcy at the moment.
  • VCYT has a Altman-Z score of 16.81. This is amongst the best in the industry. VCYT outperforms 87.26% of its industry peers.
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.81
ROIC/WACC0.52
WACC8.87%
VCYT Yearly LT Debt VS Equity VS FCFVCYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 8.15 indicates that VCYT has no problem at all paying its short term obligations.
  • VCYT has a better Current ratio (8.15) than 73.36% of its industry peers.
  • A Quick Ratio of 7.81 indicates that VCYT has no problem at all paying its short term obligations.
  • VCYT has a better Quick ratio (7.81) than 71.81% of its industry peers.
Industry RankSector Rank
Current Ratio 8.15
Quick Ratio 7.81
VCYT Yearly Current Assets VS Current LiabilitesVCYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

7

3. VCYT Growth Analysis

3.1 Past

  • VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 176.67%, which is quite impressive.
  • Looking at the last year, VCYT shows a quite strong growth in Revenue. The Revenue has grown by 16.01% in the last year.
  • The Revenue has been growing by 34.50% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%

3.2 Future

  • VCYT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.22% yearly.
  • VCYT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.74% yearly.
EPS Next Y39.38%
EPS Next 2Y26.95%
EPS Next 3Y26.37%
EPS Next 5Y21.22%
Revenue Next Year12.64%
Revenue Next 2Y12.58%
Revenue Next 3Y12.06%
Revenue Next 5Y10.74%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VCYT Yearly Revenue VS EstimatesVCYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
VCYT Yearly EPS VS EstimatesVCYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2

6

4. VCYT Valuation Analysis

4.1 Price/Earnings Ratio

  • VCYT is valuated quite expensively with a Price/Earnings ratio of 40.34.
  • VCYT's Price/Earnings ratio is rather cheap when compared to the industry. VCYT is cheaper than 90.93% of the companies in the same industry.
  • VCYT is valuated expensively when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 28.94, which means the current valuation is very expensive for VCYT.
  • 92.66% of the companies in the same industry are more expensive than VCYT, based on the Price/Forward Earnings ratio.
  • VCYT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 40.34
Fwd PE 28.94
VCYT Price Earnings VS Forward Price EarningsVCYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, VCYT is valued cheaply inside the industry as 93.24% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 95.75% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.01
EV/EBITDA 21.59
VCYT Per share dataVCYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • VCYT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • VCYT has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as VCYT's earnings are expected to grow with 26.37% in the coming years.
PEG (NY)1.02
PEG (5Y)N/A
EPS Next 2Y26.95%
EPS Next 3Y26.37%

0

5. VCYT Dividend Analysis

5.1 Amount

  • No dividends for VCYT!.
Industry RankSector Rank
Dividend Yield 0%

VCYT Fundamentals: All Metrics, Ratios and Statistics

VERACYTE INC

NASDAQ:VCYT (3/17/2026, 8:00:02 PM)

After market: 33.48 0 (0%)

33.48

+0.56 (+1.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners110.45%
Inst Owner Change-4.94%
Ins Owners0.42%
Ins Owner Change6.05%
Market Cap2.66B
Revenue(TTM)517.14M
Net Income(TTM)66.35M
Analysts82.11
Price Target50.17 (49.85%)
Short Float %6.96%
Short Ratio6.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)105.79%
Min EPS beat(2)79.03%
Max EPS beat(2)132.56%
EPS beat(4)3
Avg EPS beat(4)43.36%
Min EPS beat(4)-110.32%
Max EPS beat(4)132.56%
EPS beat(8)6
Avg EPS beat(8)164.25%
EPS beat(12)8
Avg EPS beat(12)72.71%
EPS beat(16)12
Avg EPS beat(16)65.75%
Revenue beat(2)2
Avg Revenue beat(2)3.25%
Min Revenue beat(2)3.19%
Max Revenue beat(2)3.31%
Revenue beat(4)4
Avg Revenue beat(4)3.32%
Min Revenue beat(4)1.01%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)3.84%
Revenue beat(12)11
Avg Revenue beat(12)4.44%
Revenue beat(16)15
Avg Revenue beat(16)5.09%
PT rev (1m)0.93%
PT rev (3m)1.69%
EPS NQ rev (1m)-10%
EPS NQ rev (3m)-22.76%
EPS NY rev (1m)2.37%
EPS NY rev (3m)10.57%
Revenue NQ rev (1m)0.46%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)1.2%
Revenue NY rev (3m)2.33%
Valuation
Industry RankSector Rank
PE 40.34
Fwd PE 28.94
P/S 5.14
P/FCF 21.01
P/OCF 19.52
P/B 2.03
P/tB 5.87
EV/EBITDA 21.59
EPS(TTM)0.83
EY2.48%
EPS(NY)1.16
Fwd EY3.46%
FCF(TTM)1.59
FCFY4.76%
OCF(TTM)1.72
OCFY5.12%
SpS6.51
BVpS16.48
TBVpS5.7
PEG (NY)1.02
PEG (5Y)N/A
Graham Number17.54
Profitability
Industry RankSector Rank
ROA 4.72%
ROE 5.07%
ROCE 5.82%
ROIC 4.59%
ROICexc 6.63%
ROICexgc 80.43%
OM 15.14%
PM (TTM) 12.83%
GM 70.1%
FCFM 24.49%
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 45.19%
Cap/Sales 1.87%
Interest Coverage 250
Cash Conversion 136.72%
Profit Quality 190.84%
Current Ratio 8.15
Quick Ratio 7.81
Altman-Z 16.81
F-Score8
WACC8.87%
ROIC/WACC0.52
Cap/Depr(3y)43.31%
Cap/Depr(5y)38.08%
Cap/Sales(3y)2.39%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
EPS Next Y39.38%
EPS Next 2Y26.95%
EPS Next 3Y26.37%
EPS Next 5Y21.22%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%
Revenue Next Year12.64%
Revenue Next 2Y12.58%
Revenue Next 3Y12.06%
Revenue Next 5Y10.74%
EBIT growth 1Y301.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year205.84%
EBIT Next 3Y58.94%
EBIT Next 5Y37.52%
FCF growth 1Y98.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.51%
OCF growth 3Y162.45%
OCF growth 5YN/A

VERACYTE INC / VCYT Fundamental Analysis FAQ

What is the fundamental rating for VCYT stock?

ChartMill assigns a fundamental rating of 7 / 10 to VCYT.


What is the valuation status of VERACYTE INC (VCYT) stock?

ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.


How profitable is VERACYTE INC (VCYT) stock?

VERACYTE INC (VCYT) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for VCYT stock?

The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 40.34 and the Price/Book (PB) ratio is 2.03.


What is the financial health of VERACYTE INC (VCYT) stock?

The financial health rating of VERACYTE INC (VCYT) is 8 / 10.